LEXARIA BIOSCIENCE CORP. Shareholders' Equity
LEXARIA BIOSCIENCE CORP. (LEXX) had Shareholders' Equity of $4.74 million as of 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-07-13
- 2026-05-31: Stockholders' Equity Attributable to Parent $4.74M.
- 2026-02-28: Stockholders' Equity Attributable to Parent $6.60M.
- 2025-11-30: Stockholders' Equity Attributable to Parent $4.91M.
- 2025-08-31: Stockholders' Equity Attributable to Parent $2.99M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-05-31 | $4.74M 10-Q · filed 2026-07-13 | |
| 2026-02-28 | $6.60M 10-Q · filed 2026-04-13 | |
| 2025-11-30 | $4.91M 10-Q · filed 2026-01-13 | |
| 2025-08-31 | $2.99M 10-Q · filed 2026-07-13 | |
| 2025-05-31 | $5.55M 10-Q · filed 2025-07-14 | |
| 2025-02-28 | $7.14M 10-Q · filed 2025-04-14 | |
| 2024-11-30 | $9.77M 10-Q · filed 2025-01-10 | |
| 2024-08-31 | $8.04M 10-K · filed 2025-11-28 | |
| 2024-05-31 | $10.12M 10-Q · filed 2024-07-12 | |
| 2024-02-29 | $6.52M 10-Q · filed 2024-04-09 | |
| 2023-11-30 | $3.74M 10-Q · filed 2024-01-12 | |
| 2023-08-31 | $3.04M 10-K · filed 2024-11-26 | |
| 2023-05-31 | $4.40M 10-Q · filed 2023-07-14 | |
| 2023-02-28 | $4.97M 10-Q · filed 2023-04-14 | |
| 2022-11-30 | $6.26M 10-Q/A · filed 2023-01-18 | |
| 2022-08-31 | $7.95M 10-K · filed 2023-11-20 | |
| 2022-05-31 | $9.18M 10-Q · filed 2022-07-14 | |
| 2022-02-28 | $11.22M 10-Q · filed 2022-04-11 | |
| 2021-11-30 | $11.47M 10-Q/A · filed 2023-01-18 | |
| 2021-08-31 | $13.06M 10-Q/A · filed 2023-01-18 | |
| 2021-05-31 | $10.27M 10-Q · filed 2022-04-11 | $10.27M 10-Q · filed 2021-07-15 |
| 2021-02-28 | $11.70M 10-Q · filed 2022-04-11 | $11.77M 10-Q · filed 2021-04-14 |
| 2020-11-30 | $1.82M 10-Q · filed 2022-04-11 | $1.88M 10-Q · filed 2021-01-14 |
| 2020-08-31 | $2.48M 10-Q · filed 2022-04-11 | $2.53M 10-K · filed 2020-10-15 |
| 2020-05-31 | $3.20M 10-Q · filed 2021-07-15 | $3.19M 10-Q · filed 2020-06-29 |
| 2020-02-29 | $1.92M 10-Q · filed 2021-07-15 | $1.88M 10-Q · filed 2020-04-03 |
| 2019-11-30 | $2.62M 10-Q · filed 2021-07-15 | $2.62M 10-Q · filed 2020-01-09 |
| 2019-08-31 | $2.49M 10-K · filed 2021-11-29 | $2.38M 10-K · filed 2019-11-14 |
| 2019-05-31 | $3.32M 10-Q · filed 2019-07-08 | |
| 2019-02-28 | $3.77M 10-Q · filed 2019-07-08 | |
| 2018-11-30 | $3.41M 10-Q · filed 2019-07-08 | |
| 2018-08-31 | $2.39M 10-Q · filed 2020-01-09 | |
| 2018-05-31 | $2.64M 10-Q · filed 2019-07-08 | |
| 2018-02-28 | $2.77M 10-Q · filed 2019-07-08 | |
| 2017-11-30 | $2.40M 10-Q · filed 2019-07-08 | |
| 2017-09-30 | $2.77M 10-Q · filed 2019-04-15 | |
| 2017-08-31 | $2.77M 10-Q · filed 2020-01-09 | $3.01M 10-K · filed 2017-11-27 |
| 2017-05-31 | $3.26M 10-Q · filed 2017-07-14 | |
| 2017-02-28 | $691.17K 10-Q · filed 2017-04-14 | |
| 2016-11-30 | $806.74K 10-Q · filed 2017-01-13 | |
| 2016-08-31 | $266.05K 10-K · filed 2017-11-27 | |
| 2016-05-31 | $120.69K 10-Q · filed 2016-07-13 | |
| 2016-02-29 | $264.95K 10-Q · filed 2016-04-13 | |
| 2015-11-30 | $463.81K 10-Q · filed 2016-01-08 | |
| 2015-08-31 | $772.41K 10-K · filed 2016-11-29 | |
| 2015-05-31 | $1.15M 10-Q · filed 2015-07-14 | |
| 2015-02-28 | $1.14M 10-Q · filed 2015-04-14 | |
| 2014-11-30 | $1.42M 10-Q · filed 2015-01-14 | |
| 2014-08-31 | $1.72M 10-K · filed 2015-11-27 | |
| 2014-07-31 | $3.55M 10-Q · filed 2014-11-14 | |
| 2014-04-30 | $3.73M 10-Q · filed 2014-06-12 | |
| 2014-01-31 | $2.03M 10-Q · filed 2014-03-12 | |
| 2013-10-31 | $2.10M 10-KT · filed 2014-12-09 | |
| 2013-07-31 | $2.23M 10-Q · filed 2013-09-10 | |
| 2013-04-30 | $2.26M 10-Q · filed 2013-06-12 | |
| 2013-01-31 | $2.31M 10-Q · filed 2013-03-13 | |
| 2012-10-31 | $2.42M 10-KT · filed 2014-12-09 | |
| 2012-07-31 | $2.39M 10-Q · filed 2012-09-12 | |
| 2012-04-30 | $2.32M 10-Q · filed 2012-06-07 | |
| 2012-01-31 | $2.55M 10-Q · filed 2012-03-13 | |
| 2011-10-31 | $2.66M 10-K · filed 2014-01-24 | |
| 2011-07-31 | $2.39M 10-Q · filed 2011-09-14 | |
| 2010-10-31 | $2.15M 10-K · filed 2013-01-29 | |
| 2009-10-31 | $2.30M 10-K · filed 2012-01-30 | |
| 2009-10-30 | $2.30M 10-Q · filed 2011-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |